Klotho Neurosciences today announced it has signed a nonbinding Letter of Intent to acquire select assets from Turn Biotechnologies, in a transaction anchored by a $300 million global pharma deal, according to the company. Under the proposed deal, Klotho would obtain Turn’s ERA (Epigenetic Reprogram…
Evelyne Bischof on cognition, biomarkers and the evolving science of keeping our brains younger for longer. As our bodies age, so do our brains – but the pace and pattern are far from predetermined. At this year’s Global Longevity Summit (28–30 October 2025, Geneva), leading experts will gather unde…
The DripBar, an intravenous vitamin therapy franchise, will launch a new location in Georgetown, D.C., on October 11, 2025. According to the company, this will become its latest facility in a network that already operates over 80 locations nationwide, with more than 600 in development. The Georgetow…
At LIC 2025, investors, scientists and founders explored how AI, equity and collaboration are shaping the next phase of healthspan innovation. The alpine calm of Gstaad belied the intensity of conversation within Le Grand Bellevue, where the sixth Longevity Investors Conference (LIC) gathered an inv…
Manjit Sareen reflects on the first Asia-Pacific Longevity Medicine International Summit and the launch of a global directory for clinics. There was a palpable sense of optimism in Hong Kong as experts from around the world gathered for the region’s first Longevity Medicine International Summit – a …
BlueRock Therapeutics says that its Phase I trial of bemdaneprocel (BRT-DA01), a cell therapy for Parkinson’s disease, produced positive results at 36 months. The company claims the therapy remains safe, with evidence of implanted cell survival and clinical trends consistent with earlier observation…
Circulate Health announced that a study published 22 May 2026 in the Journal of Clinical Apheresis found that therapeutic plasma exchange reduced microplastic particles in patient blood, according to the company. More than 100 patients undergoing plasma exchange at Circulate Health clinics consented…
Elysium announced the launch of The Elysium Longevity Institute (TELI), a science-first, physician-led longevity program that expands the company’s offerings to include personalized supplement and prescription protocols, peptides, vitamin injections and ongoing clinical support. TELI will be l…
Aeon Clinic has introduced targeted NAD+ IV therapy and a suite of premium IV drips at its Atlantis The Royal location in Dubai. The clinic offers tailored IV drip treatments that deliver vitamins and micronutrients directly into the bloodstream for higher absorption. Aeon Clinic highlights a specia…
Rubedo Life Sciences reported preliminary Phase 1b/2a data showing topical RLS-1496 1% cream produced a 46% reduction in actinic keratosis lesion count at four weeks in the first 18 of 24 patients evaluated, versus an 11% reduction in untreated controls. The open-label, multicenter U.S. trial assess…
